Search - tctmd.com

Displaying 441 - 460 of 4004

Sort: Relevancy | Date

Presentation TCT 2022

Stent-Free PCI (DCB Only Approach): Insights and Considerations from the SELUTION de NOVO Randomized Control Study

Presenter: Christian M. Spaulding

September 17, 2022

Presentation TCT 2022

Sirolimus DCBs: Technological Trends, Challenges and Advantages

Presenter: Ron Waksman

September 17, 2022

Presentation TCT 2022

Sirolimus Coated DCB in All-Comers EASTBOURNE (MagicTouch DCB)

Presenter: Bernardo Cortese

September 17, 2022

Presentation TCT 2022

DCB for SVD: Primary Outcomes of a Multi-Center RCT with AGENT DCB

Presenter: Paul Underwood

September 17, 2022

Presentation TCT 2022

5-Year RESTORE SVD China Trial: Restore DCB vs. DES Resolute Integrity in SVD

Presenter: ShaoLiang Chen

September 17, 2022

Presentation TCT 2022

3-Year Outcome of paclitaxel DCB vs. DES for Native Vessel Disease Treatment: Final Follow Up of the Randomized PICCOLETO II Trial

Presenter: Bernardo Cortese

September 17, 2022

Presentation TCT 2022

Time to Move Beyond ISR – My Vision of the Future for Coronary DCB Technologies

Presenter: Antonio Colombo

September 17, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Industry News

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

September 13, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Conference News ESC 2022

Less Death, Major Bleeding With Transradial Access: Meta-analysis

Michael O'Riordan

August 29, 2022

News Conference News ESC 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Michael O'Riordan

August 27, 2022

News Conference News ESC 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Michael O'Riordan

August 26, 2022

News Daily News

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

L.A. McKeown

August 05, 2022

News Daily News

CABG Bests PCI in Patients With Good Physical, Mental Health: SYNTAXES

Michael O'Riordan

July 22, 2022

News Daily News

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

Michael O'Riordan

July 18, 2022

News Daily News

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

Michael O'Riordan

July 12, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

L.A. McKeown

June 01, 2022

Advertisement

Stent-Free PCI (DCB Only Approach): Insights and Considerations from the SELUTION de NOVO Randomized Control Study

Sirolimus DCBs: Technological Trends, Challenges and Advantages

Sirolimus Coated DCB in All-Comers EASTBOURNE (MagicTouch DCB)

DCB for SVD: Primary Outcomes of a Multi-Center RCT with AGENT DCB

5-Year RESTORE SVD China Trial: Restore DCB vs. DES Resolute Integrity in SVD

3-Year Outcome of paclitaxel DCB vs. DES for Native Vessel Disease Treatment: Final Follow Up of the Randomized PICCOLETO II Trial

Time to Move Beyond ISR – My Vision of the Future for Coronary DCB Technologies

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

CV Care Around Noncardiac Surgery: New ESC Guidelines

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Less Death, Major Bleeding With Transradial Access: Meta-analysis

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Polypill Bests Usual Care in Patients With Recent MI: SECURE

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

CABG Bests PCI in Patients With Good Physical, Mental Health: SYNTAXES

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content